Panés Julián, Domènech Eugeni, Aguas Peris Marian, Nos Pilar, Riestra Sabino, Juliá de Páramo Berta, Cea-Calvo Luis, Romero Cristina, Marín-Jiménez Ignacio
Department of Gastroenterology, Hospital Clínic Barcelona, IDIBAPS, Center for Biomedical Research in Network of Liver and Digestive Diseases (CIBERehd), Barcelona, Spain.
Gastroenterology Unit, Hospital Universitari Germans Trias i Pujol (Badalona), Center for Biomedical Research in Network of Liver and Digestive Diseases (CIBERehd), Badalona, Spain.
J Gastroenterol Hepatol. 2017 Nov;32(11):1818-1824. doi: 10.1111/jgh.13795.
In ulcerative colitis (UC), the main goals of treatment are to control disease activity and normalize health-related quality of life (HRQoL). In this study, we explored the relationship between disease activity (measured using the Simple Clinical Colitis Activity Index [SCCAI]) and patient HRQoL (measured using the EuroQoL [EQ]-5D-5L).
A total of 199 patients with UC were followed for 6 months. At months 3 and 6, patients completed an online SCCAI. Within 2 days of completing the SCCAI, patients completed an at-clinic EQ-5D-5L questionnaire and the treating gastroenterologist completed the SCCAI.
A consistent and approximately linear relationship was identified between patient HRQoL and patient-completed and physician-completed SCCAIs. A lower SCCAI score corresponded to a higher EQ-5D-5L index value. Correlation between EQ-5D-5L index values and patient-completed online SCCAIs was moderate (ρ -0.49; P < 0.001) and similar to that between EQ-5D-5L index values and physician-completed SCCAIs (ρ -0.53; P < 0.001). A decrease in the EQ-5D-5L index was already observed at an SCCAI score of 2, commonly regarded as remission. A 1-point increase in the patient SCCAI corresponded to an average change of -0.027 (standard deviation, -0.032 to -0.022) in the EQ-5D-5L index, whereas a 1-point increase in the physician SCCAI corresponded to an average change of -0.030 (standard deviation, -0.036 to -0.025).
Health-related quality of life measured using the EQ-5D-5L questionnaire is proportionally related to disease activity in patients with UC. In line with the treat-to-target objective in UC, complete control of all symptoms is required to achieve optimal improvement in patient HRQoL.
在溃疡性结肠炎(UC)中,治疗的主要目标是控制疾病活动并使健康相关生活质量(HRQoL)正常化。在本研究中,我们探讨了疾病活动(使用简单临床结肠炎活动指数[SCCAI]测量)与患者HRQoL(使用欧洲五维度健康量表[EQ]-5D-5L测量)之间的关系。
共对199例UC患者进行了6个月的随访。在第3个月和第6个月时,患者完成在线SCCAI。在完成SCCAI的2天内,患者完成门诊EQ-5D-5L问卷,治疗的胃肠病学家完成SCCAI。
在患者HRQoL与患者完成的和医生完成的SCCAI之间确定了一种一致且近似线性的关系。较低的SCCAI评分对应较高的EQ-5D-5L指数值。EQ-5D-5L指数值与患者完成的在线SCCAI之间的相关性为中等(ρ -0.49;P < 0.001),与EQ-5D-5L指数值和医生完成的SCCAI之间的相关性相似(ρ -0.53;P < 0.001)。在SCCAI评分为2(通常视为缓解)时,已观察到EQ-5D-5L指数下降。患者SCCAI增加1分对应EQ-5D-5L指数平均变化-0.027(标准差,-0.032至-0.022),而医生SCCAI增加1分对应EQ-5D-5L指数平均变化-0.030(标准差,-0.036至-0.025)。
使用EQ-5D-5L问卷测量的健康相关生活质量与UC患者的疾病活动成比例相关。符合UC治疗目标的要求,需要完全控制所有症状才能实现患者HRQoL的最佳改善。